Palatin Technologies
PTN
#9923
Rank
$39.16 M
Marketcap
$23.00
Share price
4.59%
Change (1 day)
2,373.12%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -$17.3 Million USD

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$26.94 Million USD, an increase over its 2023 earnings that were of -$32.42 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$17.3 Million-35.81%
2024 -$26.94 Million-16.9%
2023 -$32.42 Million5.99%
2022 -$30.59 Million-13.7%
2021 -$35.45 Million33.25%
2020 -$26.6 Million-172.11%
2019 $36.88 M2352.33%
2018 $1.5 M-94.13%
2017 $25.62 M-154.92%
2016 -$46.67 Million3.67%
2015 -$45.02 Million878%
2014 -$4.61 Million-72.64%
2013 -$16.83 Million-33.11%
2012 -$25.15 Million77.71%
2011 -$14.16 Million
2003 -$23.97 Million29.93%
2002 -$18.45 Million36.18%
2001 -$13.55 Million
1999 -$11.24 Million6.04%
1998 -$10.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-$11.81 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-$29.49 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$0.58 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$50.55 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$66.79 M-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-$0.12 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-$55.55 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$13.09 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK